-
1
-
-
9144250366
-
Diagnosis and complications of Cushing's syndrome: A consensus statement
-
Arnaldi G, Agneli A, Atkinson AB et al, 2003 Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88: 5593-5602.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 5593-5602
-
-
Arnaldi, G.1
Agneli, A.2
Atkinson, A.B.3
-
2
-
-
0028339489
-
Morbidity and mortality in Cushing's disease: An epidemiological approach
-
Extabe J, Vasquez JA, 1994. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol 40: 479-484.
-
(1994)
Clin Endocrinol
, vol.40
, pp. 479-484
-
-
Extabe, J.1
Vasquez, J.A.2
-
3
-
-
17744362051
-
Incidence and late prognosis of Cushing's syndrome: A population based study
-
Lindholm J, Juul S, Jørgensen JOL, et al, 2001 Incidence and late prognosis of Cushing's syndrome: a population based study. J Clin Endocrinol Metab 86: 117-123.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 117-123
-
-
Lindholm, J.1
Juul, S.2
Jørgensen, J.O.L.3
-
4
-
-
33845489470
-
High prevalence of pituitary adenomas: A cross sectional study in the province of Liège, Belgium
-
Daly AF, Rixhon AF, Adam C, et al, 2006 High prevalence of pituitary adenomas: a cross sectional study in the province of Liège, Belgium. J Clin Endocrinol Metab 91: 4769-4775.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 4769-4775
-
-
Daly, A.F.1
Rixhon, A.F.2
Adam, C.3
-
5
-
-
76649132060
-
Prevalence of pituitary adenomas: A community based study in Banbary (Oxfordshire, UK)
-
Fernandez A, Karavitaki N, Wass JA, 2010 Prevalence of pituitary adenomas: a community based study in Banbary (Oxfordshire, UK). Clin Endocrinol 72: 377-382.
-
(2010)
Clin Endocrinol
, vol.72
, pp. 377-382
-
-
Fernandez, A.1
Karavitaki, N.2
Wass, J.A.3
-
6
-
-
33947513244
-
Mortality in patients treated for Cushing's disease is increased compared with patients treated for nonfunctioning pituitary macroadenoma
-
Dekkers OM, Biermasz NR, Pereira AM et al, 2007 Mortality in patients treated for Cushing's disease is increased compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 92: 976-981.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 976-981
-
-
Dekkers, O.M.1
Biermasz, N.R.2
Pereira, A.M.3
-
7
-
-
0033343114
-
Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure
-
Colao A, Pivonello R, Spiezia S, et al, 1999 Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84: 2664-2672.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 2664-2672
-
-
Colao, A.1
Pivonello, R.2
Spiezia, S.3
-
8
-
-
79952284005
-
Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK
-
Clayton RN, Raskauskiene D, Reulen RC, Jones PW, 2011 Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK. J Clin Endocrinol Metab 96: 632-42.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 632-642
-
-
Clayton, R.N.1
Raskauskiene, D.2
Reulen, R.C.3
Jones, P.W.4
-
9
-
-
80052526859
-
Mortality and morbidity in Cushing's syndrome in New Zealand
-
Bolland MJ, Holdaway IM, Berkeley JE, et al, 2011 Mortality and morbidity in Cushing's syndrome in New Zealand. Clin Endocrinol 75: 436-442.
-
(2011)
Clin Endocrinol
, vol.75
, pp. 436-442
-
-
Bolland, M.J.1
Holdaway, I.M.2
Berkeley, J.E.3
-
10
-
-
76149137381
-
Metabolic, cardiovascular and cerebrovascular outcomes in growth hormone deficient subjects with previous Cushing's disease or nonfunctioning pituitary adenoma
-
Webb SM, Mo D, Lamberts SW, et al 2010 Metabolic, cardiovascular and cerebrovascular outcomes in growth hormone deficient subjects with previous Cushing's disease or nonfunctioning pituitary adenoma. J Clin Endocrinol Metab 95: 630-638.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 630-638
-
-
Webb, S.M.1
Mo, D.2
Lamberts, S.W.3
-
11
-
-
69949093791
-
Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome
-
Barahona MJ, Sucunza N, Resmini E, et al, 2009 Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome. J Clin Endocrinol Metab 94: 3365-71.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 3365-3371
-
-
Barahona, M.J.1
Sucunza, N.2
Resmini, E.3
-
12
-
-
0015387624
-
Operative treatment, surgical approach and related complications in 195 operations upon the adrenal glands
-
Bilchert-Toft M, Bagerskov A, Lockwood K, Hasner E, 1972 Operative treatment, surgical approach and related complications in 195 operations upon the adrenal glands. Surg Gynecol Obstet 135: 261-266.
-
(1972)
Surg Gynecol Obstet
, vol.135
, pp. 261-266
-
-
Bilchert-Toft, M.1
Bagerskov, A.2
Lockwood, K.3
Hasner, E.4
-
13
-
-
0018168511
-
Surgical management of Cushing's syndrome
-
Delaney JP, Solomkin JS, Jacobson ME, Doe RP, 1978 Surgical management of Cushing's syndrome. Surgery 84: 465-470.
-
(1978)
Surgery
, vol.84
, pp. 465-470
-
-
Delaney, J.P.1
Solomkin, J.S.2
Jacobson, M.E.3
Doe, R.P.4
-
14
-
-
0014817504
-
Immediate complications of adrenal surgery
-
Pezzulich RA, Mannix Jr H, 1970 Immediate complications of adrenal surgery. Ann Surg 172: 125-130.
-
(1970)
Ann Surg
, vol.172
, pp. 125-130
-
-
Pezzulich, R.A.1
Mannix Jr, H.2
-
15
-
-
0017264117
-
Thromboembolic complications, heparin treatment in increase in coagulation factors in Cushing's syndrome
-
Sjöberg HE, Blombäck M, Granberg PO, 1976 Thromboembolic complications, heparin treatment in increase in coagulation factors in Cushing's syndrome. Acta Med Scand 199: 95-98.
-
(1976)
Acta Med Scand
, vol.199
, pp. 95-98
-
-
Sjöberg, H.E.1
Blombäck, M.2
Granberg, P.O.3
-
16
-
-
0020602708
-
Thromboembolic complications in Cushing's syndrome
-
Small M, Lowe GD, Forbes CD, Thomson JA, 1983 Thromboembolic complications in Cushing's syndrome. Clin Endocrinol 19: 503-511.
-
(1983)
Clin Endocrinol
, vol.19
, pp. 503-511
-
-
Small, M.1
Lowe, G.D.2
Forbes, C.D.3
Thomson, J.A.4
-
17
-
-
0032725912
-
Complications in contemporary series of patients who underwent transphenoidal surgery for Cushing's disease
-
Semple PL, Lews ER Jr, 1999 Complications in contemporary series of patients who underwent transphenoidal surgery for Cushing's disease. J Neurosurg 91: 175-179.
-
(1999)
J Neurosurg
, vol.91
, pp. 175-179
-
-
Semple, P.L.1
Lews Jr., E.R.2
-
18
-
-
0034505171
-
An institutional experience with 40 first lateral transperitoneal laparoscopic adrenalectomies
-
Sirén J, Haglund C, Haapiainen R, 2000 An institutional experience with 40 first lateral transperitoneal laparoscopic adrenalectomies. Surg Laparosc Endosc Percutan Tech 10: 382-386.
-
(2000)
Surg Laparosc Endosc Percutan Tech
, vol.10
, pp. 382-386
-
-
Sirén, J.1
Haglund, C.2
Haapiainen, R.3
-
19
-
-
0036224824
-
Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single center using strict criteria for remission
-
Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF, 2002 Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single center using strict criteria for remission. Clin Endocrinol 56: 541-551.
-
(2002)
Clin Endocrinol
, vol.56
, pp. 541-551
-
-
Rees, D.A.1
Hanna, F.W.2
Davies, J.S.3
Mills, R.G.4
Vafidis, J.5
Scanlon, M.F.6
-
20
-
-
0036342522
-
Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome
-
Boscaro M, Sonino N, Scarda A, et al, 2002 Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab 87: 3662-3666.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 3662-3666
-
-
Boscaro, M.1
Sonino, N.2
Scarda, A.3
-
21
-
-
11344284696
-
Complications after trans-sphenoidal surgery: Our experience and review of the literature
-
Sudhakar N, Ray A, Vafidis JA, et al, 2004 Complications after trans-sphenoidal surgery: our experience and review of the literature. Br J Neurosurg 18: 507-512.
-
(2004)
Br J Neurosurg
, vol.18
, pp. 507-512
-
-
Sudhakar, N.1
Ray, A.2
Vafidis, J.A.3
-
23
-
-
68549125121
-
Hypercoagulable state in Cushing's syndrome: A systematic review
-
Van Zaane B, Nur E, Squizzato A, et al, 2009 Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab 94: 2743-2751.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 2743-2751
-
-
van Zaane, B.1
Nur, E.2
Squizzato, A.3
-
24
-
-
77957836538
-
Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: Results from a prospective study before and after surgery
-
Manetti L, Bogazzi F, Govanetti C, et al, 2010 Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery. Eur J Endocrinol 163: 783-791.
-
(2010)
Eur J Endocrinol
, vol.163
, pp. 783-791
-
-
Manetti, L.1
Bogazzi, F.2
Govanetti, C.3
-
25
-
-
80655147300
-
Incidence of venous thromboembolism in patients with Cushing's syndrome: A multicenter cohort study
-
Stuijver DJF, van Zaane B, Feelders RA, et al, 2011 Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study. J Clin Endocrinol Metab 96: 3525-3532.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 3525-3532
-
-
Stuijver, D.J.F.1
van Zaane, B.2
Feelders, R.A.3
-
26
-
-
46049090201
-
Prevention of venous thromboembolism. American College of Chest Physicians Evidence-based clinical practice guidelines
-
Geerts WH, Bergqvist D, Pineo GF, et al, 2008 Prevention of venous thromboembolism. American College of Chest Physicians Evidence-based clinical practice guidelines. 8th ed Chest 133: 3815-4535.
-
(2008)
8th ed Chest
, vol.133
, pp. 3815-4535
-
-
Geerts, W.H.1
Bergqvist, D.2
Pineo, G.F.3
-
28
-
-
3042718111
-
Atherothrombosis: A widespread disease with unpredictable and life-threatening consequences
-
Viles-Gonzales FJ, Fuster V, Badimon JJ, 2004 Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J 25: 1197-1207.
-
(2004)
Eur Heart J
, vol.25
, pp. 1197-1207
-
-
Viles-Gonzales, F.J.1
Fuster, V.2
Badimon, J.J.3
-
29
-
-
0037971530
-
Left ventricular and functional characteristics in Cushing's syndrome
-
Muiesan ML, Lupia M, Salvetti M, et al, 2003 Left ventricular and functional characteristics in Cushing's syndrome. J American College Cardiol 41: 2275-2279.
-
(2003)
J American College Cardiol
, vol.41
, pp. 2275-2279
-
-
Muiesan, M.L.1
Lupia, M.2
Salvetti, M.3
-
30
-
-
73249137996
-
Hyperthrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome
-
Rizzoni D, Porteri E, De Ciuceis C, et al, 2009 Hyperthrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome. J Clin Endocrinol Metab 94: 5010-5018.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 5010-5018
-
-
Rizzoni, D.1
Porteri, E.2
de Ciuceis, C.3
-
31
-
-
33646830648
-
Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: A clinical review
-
Duprez DA, 2006 Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review. J Hypertens 24: 983-991.
-
(2006)
J Hypertens
, vol.24
, pp. 983-991
-
-
Duprez, D.A.1
-
32
-
-
18244365097
-
Microvascular effects of aldosterone and angiotensin type 2 receptors
-
Pallone TL, 2005 Microvascular effects of aldosterone and angiotensin type 2 receptors. Hypertension 45: 845-846.
-
(2005)
Hypertension
, vol.45
, pp. 845-846
-
-
Pallone, T.L.1
-
33
-
-
42349086417
-
Glucocorticoid-related signaling effects in vascular smooth muscle cells
-
Molnar GA, Lindschau C, Dubrovska G, et al, 2008 Glucocorticoid-related signaling effects in vascular smooth muscle cells. Hypertension 51: 1372-1378.
-
(2008)
Hypertension
, vol.51
, pp. 1372-1378
-
-
Molnar, G.A.1
Lindschau, C.2
Dubrovska, G.3
-
34
-
-
0038305844
-
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease remission
-
Faggiano A, Pivonello R, Spiezia S, et al, 2003 Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease remission. J Clin Endocrinol Metab 88: 2527-2533.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 2527-2533
-
-
Faggiano, A.1
Pivonello, R.2
Spiezia, S.3
-
35
-
-
33745927396
-
Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: Comparison with a population matched for similar cardiovascular risk factors
-
Albiger N, Testa RM, Almoto B, et al, 2006 Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors. Horm Metab Res 38: 405-410.
-
(2006)
Horm Metab Res
, vol.38
, pp. 405-410
-
-
Albiger, N.1
Testa, R.M.2
Almoto, B.3
-
36
-
-
77956526190
-
Cardiovascular disease in Cushing's syndrome: Heart versus vasculature
-
De Leo M, Pivonello R, Auriemma RS, et al, 2010 Cardiovascular disease in Cushing's syndrome: heart versus vasculature. Neuroendocrinology 92: Suppl 1: 50-54.
-
(2010)
Neuroendocrinology
, vol.92
, Issue.SUPPL 1
, pp. 50-54
-
-
de Leo, M.1
Pivonello, R.2
Auriemma, R.S.3
-
37
-
-
35348897820
-
Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's syndrome
-
Baykan M, Erem C, Gedikli O, et al, 2007 Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's syndrome. Endocrine 31: 300-304.
-
(2007)
Endocrine
, vol.31
, pp. 300-304
-
-
Baykan, M.1
Erem, C.2
Gedikli, O.3
-
38
-
-
4043175422
-
Hyperhomocystinemia in patients with Cushing's syndrome
-
Terzolo M, Allesino B, Bosio S, et al, 2004 Hyperhomocystinemia in patients with Cushing's syndrome. J Clin Endocrinol Metab 89: 3745-3751.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 3745-3751
-
-
Terzolo, M.1
Allesino, B.2
Bosio, S.3
-
39
-
-
48949116992
-
Soluble adhesion molecule levels in patients with Cushing's syndrome before and after cure
-
Ermetici F, Malavazos AE, Corbetta S, et al, 2008 Soluble adhesion molecule levels in patients with Cushing's syndrome before and after cure. J Endocrinol Invest 31: 389-392.
-
(2008)
J Endocrinol Invest
, vol.31
, pp. 389-392
-
-
Ermetici, F.1
Malavazos, A.E.2
Corbetta, S.3
-
40
-
-
48949116994
-
Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome
-
Kristo C, Ueland T, Godanog K, Aukrust P, Bollerslev J, 2008 Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome. J Endocrinol Invest 31: 400-405.
-
(2008)
J Endocrinol Invest
, vol.31
, pp. 400-405
-
-
Kristo, C.1
Ueland, T.2
Godanog, K.3
Aukrust, P.4
Bollerslev, J.5
-
41
-
-
0020069588
-
Increased factor VIII associated activities in Cushing's syndrome: A probable hypercoagulable state
-
Dal Bo Zanon R, Fornasiero L, Boscaro M, Vappellato G, Fabris F, Girolami A, 1982 Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state. Thromb Hemost 47: 116-117.
-
(1982)
Thromb Hemost
, vol.47
, pp. 116-117
-
-
dal Bo Zanon, R.1
Fornasiero, L.2
Boscaro, M.3
Vappellato, G.4
Fabris, F.5
Girolami, A.6
-
42
-
-
70349578944
-
Hypercoagulability in Cushing's syndrome: The role of specific hemostatic and fibrinolytic markers
-
Kastelan D, Dusek T, Kraljevic I, et al, 2009 Hypercoagulability in Cushing's syndrome: the role of specific hemostatic and fibrinolytic markers. Endocr 36: 70-74.
-
(2009)
Endocr
, vol.36
, pp. 70-74
-
-
Kastelan, D.1
Dusek, T.2
Kraljevic, I.3
-
43
-
-
67649373249
-
Blood coagulation and fibrinolysis in patients with Cushing's syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor and unchanged thrombin-activatable fibrinolysis inhibitor levels
-
Erem C, Nuhoglu I, Yilmaz M, et al, 2009 Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor and unchanged thrombin-activatable fibrinolysis inhibitor levels. J Endocrinol Invest 32: 169-174.
-
(2009)
J Endocrinol Invest
, vol.32
, pp. 169-174
-
-
Erem, C.1
Nuhoglu, I.2
Yilmaz, M.3
-
44
-
-
0033925705
-
Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma
-
Ambrosi B, Sartorio A, Pizzocaro A, Passini E, Bottasso B, Federici A, 2000 Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma. Exp Clin Endocrinol Diab 108: 294-298.
-
(2000)
Exp Clin Endocrinol Diab
, vol.108
, pp. 294-298
-
-
Ambrosi, B.1
Sartorio, A.2
Pizzocaro, A.3
Passini, E.4
Bottasso, B.5
Federici, A.6
-
45
-
-
33744809252
-
Effects of short term glucocorticoids on haemostatic factors in healthy volunteers
-
Brotman DJ, Girod JP, Posh A, et al, 2006 Effects of short term glucocorticoids on haemostatic factors in healthy volunteers. Thromb Res 118: 247-252.
-
(2006)
Thromb Res
, vol.118
, pp. 247-252
-
-
Brotman, D.J.1
Girod, J.P.2
Posh, A.3
-
46
-
-
0021847275
-
Hemostatic parameters in Cushing's syndrome
-
Ikkala E, Myllyla G, Pelkonen R, Rasi V, Viinikka L, Ylikorkala O, 1985 Hemostatic parameters in Cushing's syndrome. Acta Med Scand 217: 507-511.
-
(1985)
Acta Med Scand
, vol.217
, pp. 507-511
-
-
Ikkala, E.1
Myllyla, G.2
Pelkonen, R.3
Rasi, V.4
Viinikka, L.5
Ylikorkala, O.6
-
47
-
-
27144545040
-
High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men
-
Jilma B, Cvitko T, Winter-Fabry A, Petroczi K, Quehenberger P, Blann AD, 2005 High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men. Thromb Hemost 94: 797-801.
-
(2005)
Thromb Hemost
, vol.94
, pp. 797-801
-
-
Jilma, B.1
Cvitko, T.2
Winter-Fabry, A.3
Petroczi, K.4
Quehenberger, P.5
Blann, A.D.6
-
48
-
-
33947503997
-
Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high risk patients with hypertension: A sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial
-
Varughese GI, Patel JV, Tomson J, Blann AD, Hughes EA, Lip GY, 2007 Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial. J Intern Med 261: 384-391.
-
(2007)
J Intern Med
, vol.261
, pp. 384-391
-
-
Varughese, G.I.1
Patel, J.V.2
Tomson, J.3
Blann, A.D.4
Hughes, E.A.5
Lip, G.Y.6
-
49
-
-
0034001980
-
Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome
-
Fatti LM, Bottasso B, Invitti C, Coppola R, Cavanigni F, Mannucci PM, 2000 Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. J Endocrinol Invest 23: 145-150.
-
(2000)
J Endocrinol Invest
, vol.23
, pp. 145-150
-
-
Fatti, L.M.1
Bottasso, B.2
Invitti, C.3
Coppola, R.4
Cavanigni, F.5
Mannucci, P.M.6
-
50
-
-
0032927792
-
Abnormalities in von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome
-
Casonato A, Pontara E, Boscaro M, et al, 1999 Abnormalities in von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. Blood Coagul Fibrinolysis 10: 145-151.
-
(1999)
Blood Coagul Fibrinolysis
, vol.10
, pp. 145-151
-
-
Casonato, A.1
Pontara, E.2
Boscaro, M.3
-
51
-
-
0022181945
-
Further studies on the hypercoagulable state of patients with Cushing's syndrome
-
Patrassi GM, Dal Bo Zanon R, Boscaro M, Martinelli S, Girolami A, 1985 Further studies on the hypercoagulable state of patients with Cushing's syndrome. Thromb Hemost 54: 518-520.
-
(1985)
Thromb Hemost
, vol.54
, pp. 518-520
-
-
Patrassi, G.M.1
dal Bo Zanon, R.2
Boscaro, M.3
Martinelli, S.4
Girolami, A.5
-
52
-
-
37249027758
-
Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: Lesson learned from Cushing's syndrome
-
Casonato A, Daidone V, Sartorello F, et al, 2008 Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: lesson learned from Cushing's syndrome. Br J Hematol 140: 230-236.
-
(2008)
Br J Hematol
, vol.140
, pp. 230-236
-
-
Casonato, A.1
Daidone, V.2
Sartorello, F.3
-
53
-
-
67650676743
-
Effects of high-dose dexamethasone on endothelial haemostatic gene expression and neutrophil adhesion
-
Kerachian MA, Cournoyer D, Harvey EJ, et al, 2009 Effects of high-dose dexamethasone on endothelial haemostatic gene expression and neutrophil adhesion. J Steroid Biochem Mol Biol 116: 127-133.
-
(2009)
J Steroid Biochem Mol Biol
, vol.116
, pp. 127-133
-
-
Kerachian, M.A.1
Cournoyer, D.2
Harvey, E.J.3
-
54
-
-
77956548957
-
Coagulopathy in Cushing's syndrome
-
Trementino L, Arnaldi G, Appolloni G, et al, 2010 Coagulopathy in Cushing's syndrome. Neuroendocrinology 92: Suppl 1: 55-59.
-
(2010)
Neuroendocrinology
, vol.92
, Issue.SUPPL 1
, pp. 55-59
-
-
Trementino, L.1
Arnaldi, G.2
Appolloni, G.3
-
55
-
-
34648847176
-
Testing for thrombophilia: An evidence-based approach
-
Merriman L, Greaves M, 2006 Testing for thrombophilia: an evidence-based approach. Postgrad Med J 82: 699-704.
-
(2006)
Postgrad Med J
, vol.82
, pp. 699-704
-
-
Merriman, L.1
Greaves, M.2
-
56
-
-
0027081188
-
The fibrinolytic potential in patients with Cushing's disease: A clue to their hypercoagulable state
-
Patrassi GM, Sartori MT, Viero ML, Scarano L, Boscaro M, Girolami A, 1992 The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state. Blood Coagul Fibrinolysis 3: 789-793.
-
(1992)
Blood Coagul Fibrinolysis
, vol.3
, pp. 789-793
-
-
Patrassi, G.M.1
Sartori, M.T.2
Viero, M.L.3
Scarano, L.4
Boscaro, M.5
Girolami, A.6
-
57
-
-
0038660605
-
Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in Hep G2 cells
-
Boffa MB, Hamill JD, Maret D, et al, 2003 Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in Hep G2 cells. J Biol Chem 278: 9250-9257.
-
(2003)
J Biol Chem
, vol.278
, pp. 9250-9257
-
-
Boffa, M.B.1
Hamill, J.D.2
Maret, D.3
-
58
-
-
0021063386
-
Glucocorticoids inhibit plasminogen activator production by endothelial cells
-
Laug WE, 1983 Glucocorticoids inhibit plasminogen activator production by endothelial cells. Thromb Hemost 50: 888-892.
-
(1983)
Thromb Hemost
, vol.50
, pp. 888-892
-
-
Laug, W.E.1
-
59
-
-
0019957348
-
Paradoxical effects of glucocorticoids on regulation of plasminogen activator activity of rat hepatoma cells
-
Barouski-Miller PA, Gelehrter TD, 1982 Paradoxical effects of glucocorticoids on regulation of plasminogen activator activity of rat hepatoma cells. Cell Biol 79: 2319-232.
-
(1982)
Cell Biol
, vol.79
, pp. 2319-2320
-
-
Barouski-Miller, P.A.1
Gelehrter, T.D.2
-
60
-
-
0025213997
-
Dexamethasone-induces plasminogen activator inhibitor: Characterization, purification and preparation of monoclonal anti-bodies
-
Oikarinen A, Hoythya M, Jarvinen M, 1990 Dexamethasone-induces plasminogen activator inhibitor: characterization, purification and preparation of monoclonal anti-bodies. Arch Dermatol Res 282: 153-158.
-
(1990)
Arch Dermatol Res
, vol.282
, pp. 153-158
-
-
Oikarinen, A.1
Hoythya, M.2
Jarvinen, M.3
-
61
-
-
0033323792
-
Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: Stimulation by glucocorticoids and inhibition by catecholamines
-
Halleux CM, Declerck PJ, Tran SL, Detry R, Birchard SM, 1999 Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines. J Cin Endocrinol Metab 84: 4097-4105.
-
(1999)
J Cin Endocrinol Metab
, vol.84
, pp. 4097-4105
-
-
Halleux, C.M.1
Declerck, P.J.2
Tran, S.L.3
Detry, R.4
Birchard, S.M.5
-
62
-
-
0028233247
-
Induction of plasminogen activator inhibitor-1 in HepG2 human hepatoma cells by mediators of the Acute phase response
-
Healy AM, Gelerhrter TD, 1994 Induction of plasminogen activator inhibitor-1 in HepG2 human hepatoma cells by mediators of the Acute phase response. J Biol Chem 269: 19095-19100.
-
(1994)
J Biol Chem
, vol.269
, pp. 19095-19100
-
-
Healy, A.M.1
Gelerhrter, T.D.2
-
63
-
-
0033000074
-
Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue
-
Morange PE, Aubert J, Peiretti F, et al, 1999 Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes 48: 890-895.
-
(1999)
Diabetes
, vol.48
, pp. 890-895
-
-
Morange, P.E.1
Aubert, J.2
Peiretti, F.3
-
64
-
-
0023793663
-
Tpe 1 plasminogen activator inhibitor gene: Functional analysis and glucocorticoid regulation of its promoter
-
van Zonneveld AJ, Curriden SA, Loskutoff DK, 1988 Tpe 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter. Proct Natl Acad Sci USA 85: 5525-5529.
-
(1988)
Proct Natl Acad Sci USA
, vol.85
, pp. 5525-5529
-
-
van Zonneveld, A.J.1
Curriden, S.A.2
Loskutoff, D.K.3
-
65
-
-
11444252248
-
Dexamethasone increased plasminogen activator inhibitor-1 expression on human umbilical vein endothelial cells: An additive effect to tumor necrosis factor-α
-
Yamamoto Y, Ishiyu A, Ikeda H, Otsuka N, Yoshiki T, 2004 Dexamethasone increased plasminogen activator inhibitor-1 expression on human umbilical vein endothelial cells: an additive effect to tumor necrosis factor-α. Pathobiology 71: 295-301.
-
(2004)
Pathobiology
, vol.71
, pp. 295-301
-
-
Yamamoto, Y.1
Ishiyu, A.2
Ikeda, H.3
Otsuka, N.4
Yoshiki, T.5
-
66
-
-
58649112835
-
Polycythemia as the first manifestation of Cushing's disease
-
Dusek T, Kastelan D, Solak M, et al, 2008 Polycythemia as the first manifestation of Cushing's disease. J Endocrinol Invest 31: 940.
-
(2008)
J Endocrinol Invest
, vol.31
, pp. 940
-
-
Dusek, T.1
Kastelan, D.2
Solak, M.3
-
67
-
-
8044235654
-
The duration of oral anticoagulant therapy after a second episode of venous thromboembolism
-
Schulman S, Granqvist S, Holmstrom M, et al, 1997 The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 336: 393-398.
-
(1997)
N Engl J Med
, vol.336
, pp. 393-398
-
-
Schulman, S.1
Granqvist, S.2
Holmstrom, M.3
-
68
-
-
0027377650
-
Continuous registration of thrombin generation in plasma, its use for the determination of thrombin potential
-
Hemker HC, Wielders S, Kessels H, Beguin S, 1993 Continuous registration of thrombin generation in plasma, its use for the determination of thrombin potential. Thromb Haemost 70: 617-624.
-
(1993)
Thromb Haemost
, vol.70
, pp. 617-624
-
-
Hemker, H.C.1
Wielders, S.2
Kessels, H.3
Beguin, S.4
-
69
-
-
27244439233
-
The measurement and application of thrombin generation
-
Baglin T, 2005 The measurement and application of thrombin generation. Br J Haematol 130: 653-661.
-
(2005)
Br J Haematol
, vol.130
, pp. 653-661
-
-
Baglin, T.1
-
70
-
-
0034779086
-
Biochemical basis for the hypercoagulable state seen in Cushing syndrome
-
Jacoby R, Owings T, Ortega R, Gosselin R, Feldman E, 2001 Biochemical basis for the hypercoagulable state seen in Cushing syndrome. Arch Surg 136: 1003-1007.
-
(2001)
Arch Surg
, vol.136
, pp. 1003-1007
-
-
Jacoby, R.1
Owings, T.2
Ortega, R.3
Gosselin, R.4
Feldman, E.5
|